Can you tell us about Intrasense and its association with Modi Medicare?
| Patrick Mayette |
INTRASENSE has been closely working with the company Modi Medicare, and its CEO Jigish Modi, for more than two years. Modi Medicare’s expertise on our Myrian platform means high service quality for our Indian customers.
Tell us about Myrian and its applications for radiologists, surgeons and clinicians in their daily practice.
INTRASENSE develops a new generation of advanced software solutions for the review and analysis of medical images. Our Myrian platform is a full-fledged multimodality workspace with a user-friendly interface and features not only high level functions but also powerful protocols to optimise clinical workflows and boost productivity. A comprehensive set of original clinical modules are available as options for liver, lung, colon, vessels, breast, heart, vessels and brain. The XL-ONCO module is the most advanced oncology follow-up application on the market.
These applications are a key asset for radiologists, surgeons, oncologists and specialists:
- They improve the efficiency of image reading and the accuracy of diagnosis
- They support surgery and therapy planning and assessment
- They allow the early and accurate evaluation of a treatment
What is the USP of Myrian?
Myrian is the first true multimodality workstation in the market with the capacity to combine, compare and process images from several modalities simultaneously. This is essential to allow the comprehensive analysis of patient information, particularly in chronic diseases.
Myrian is also a very versatile and customisable platform that perfectly adapts itself to the exact needs of each user and each hospital. It seamlessly fits in the hospital information system (PACS, RIS, modalities) to enhance its capacity. Its modularity allows step-by-step investment. It is available in workstations as well as in application server configuration.
| Depending on the application & imaging modality there is a family of different modules Such as: | ||
| MYRIAN FAMILY: BASE PLATFORMS | SPECIALITY MODULES | |
| PRO (Basic CR/DR Workstation) ADVANCED (Double oblique MPR/ MIP, CPR, etc.) EXPERT (3D Workstation) EXPERT VL (3D With Volumetry W/s) XL-REGISTRATION (Elastic Registration) XL-4D NAVIGATOR |
XP-LIVER XP-LUNG XP-LUNGNODULE XP-COLON XL-XP-2D/3D STITCHING XL ONCOLOGY (RECIST1.1) XP ORTHO |
XT CARDIAC MRI XT BRAIN MRI XP-VESSELS(CT/MRI) XT DENTAL XP-COLONCAD RADIOTHERAPY PLANNING XP-FUSION |
How has been the overall market response to Myrian in the Indian market?
Indian market is a huge market and we have seen very good response on very specific needs as liver post-processing diagnosis at the beginning. With all the new equipment on CT and MRIs, India has overcome many high challenges and is now targetting very high-end modules such as Brain MR and Cardiac MR.
Can you share with us some significant achievements over the last few years, global or in India?
Today, INTRASENSE serves over 500 customers including prestigious university hospitals in over 25 countries. Myrian is used by more than 2000 users every day. Our outstanding technology and our fast growth have allowed us to introduce the company on the NYSE Euronext market in February 2012. This is a key asset to accelerate the development of our platform and our presence in strategic markets such as India.
We believe that India is a high potential market. The high-level of medical education and massive investments in the healthcare infrastructure are strong drivers for growth.
What are the opportunities and bottlenecks in the Indian radiology market for your business?
Today, we can see a very large scope of opportunities, from equipping PACS companies with advanced visualisation software to answering to global tenders with server base software.
How are you poised for growth in the near future?
Our platform is very well accepted on the global market and regarded as a competitive alternative or complement to modality vendors’ workstations as well as a smart way to enhance existing PACS installations. With three major product launches every year, we move fast to offer state-of-the-art technology to our users.
Myrian XL-ONCO for cancer therapy evaluation or Myrian XP-LIVER for liver surgery planning are considered as the best solutions in their categories. On October 15, 2012, we will launch Myrian XP-BREAST, the most advanced breast MRI viewer on the market, with outstanding reading performance and smart clinical workflows and post-processing features. Combined with high quality services, these solutions will continue to drive our global growth and market leadership as the most innovative visualisation software company.